We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 285.00
Ask: 286.00
Change: 5.00 (1.78%)
Spread: 1.00 (0.351%)
Open: 283.00
High: 286.00
Low: 283.00
Prev. Close: 281.00
DIG Live PriceLast checked at -
Dunedin Income Growth is an Investment Trust

To achieve growth of income and capital from a portfolio invested mainly in companies listed or quoted in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

21 Sep 2023 07:00

RNS Number : 1247N
Dunedin Income Growth Inv Tst PLC
21 September 2023
 

DUNEDIN INCOME GROWTH INVESTMENT TRUST PLC

 

HALF YEARLY REPORT FOR THE SIX MONTHS ENDED 31 JULY 2023

Legal Entity Identifier (LEI):  549300PPXLZPR5JTL763

 

 

 

HIGHLIGHTS FOR THE PERIOD

- NAV total return of 5.5%, outperforming the total return of 0.8% from the FTSE All-Share Index.

- Against a flat market return, investment performance has been positive, aided by the Company's focus on higher quality areas of the market, coupled with good stock selection.

- Dividend yield of 4.6% at the period end.

 

INVESTMENT OBJECTIVE

The objective of Dunedin Income Growth Investment Trust PLC is to achieve growth of income and capital from a portfolio invested mainly in companies listed or quoted in the United Kingdom that meet the Company's sustainable and responsible investing criteria as set by the Board.

 

BENCHMARK

The Company's benchmark is the FTSE All-Share Index (total return). Performance is measured on a net asset value total return basis over the long-term.

 

Performance Highlights

Net asset value total return per Ordinary shareAB 

Share price total return per Ordinary shareA

Six months ended 31 July 2023

Six months ended 31 July 2023

+5.5%

(0.4)%

Year ended 31 January 2023

+2.4%

Year ended 31 January 2023

(0.9)%

Revenue return per Ordinary share

FTSE All-Share Index total return

Six months ended 31 July 2023

Six months ended 31 July 2023

8.25p

+0.8%

Six months ended 31 July 2022

8.54p

Year ended 31 January 2023

+5.2%

Dividend yieldA

Discount to net asset valueAB

As at 31 July 2023

As at 31 July 2023

4.6%

(8.4)%

As at 31 January 2023

4.5%

As at 31 January 2023

(2.9)%

A Considered to be an Alternative Performance Measure.

B With debt at fair value (including income).

Financial Calendar

Expected payment dates of quarterly dividends

24 November 202323 February 202431 May 202430 August 2024

Financial year end

31 January 2024

Expected announcement of resultsfor year ended 31 January 2024

March 2024

Annual General Meeting (London)

May 2024

Financial Highlights

31 July 2023

31 January 2023

% change

Total assets (£'000)A

500,934

492,105

+1.8

Equity shareholders' funds (£'000)

456,610

448,605

+1.8

Market capitalisation (£'000)

423,974

435,898

(2.7)

Net asset value per Ordinary share

308.02p

302.57p

+1.8

Net asset value per Ordinary share with debt at fair valueB

312.17p

302.80p

+3.1

Share price per Ordinary share (mid)

286.00p

294.00p

(2.7)

Discount to net asset value with debt at fair valueB

(8.4%)

(2.9%)

Revenue return per Ordinary shareC

8.25p

8.54p

(3.4)

Gearing - netB

9.7%

7.1%

A Defined as total assets per the Statement of Financial Position less current liabilities (before deduction of bank loans and Loan Notes).

B Considered to be an Alternative Performance Measure.  

C Figure for 31 July 2023 is for six months to that date. Figure for 31 January 2023 is for the six months to 31 July 2022.

 

For further information, please contact:

 

Stephanie Hocking

William Hemmings

abrdn Fund Managers Limited

0131 372 2200

Chairman's Statement

Review of the Period

Looking back over past the few years, our Half Yearly Report has often corresponded with significant geopolitical events such as the global pandemic in 2020 and the invasion of Ukraine in 2022. In contrast, the first six months of this financial year saw a return to more conventional points of focus: a UK economy struggling for growth amidst the steepest inflation in 40 years, trying to assess the extent of central bank interest rate increases, concerns over growth in China and speculation on the potential of new developments in Artificial Intelligence. Against that backdrop, the Company delivered a positive absolute return for the six month period ended 31 July 2023. The net asset value ("NAV") increased by 5.5% on a total return basis, exceeding that of its benchmark, the FTSE All-Share Index, which produced a total return of 0.8%. The share price total return for the period was -0.4%, reflecting a widening of the discount at which the Company's shares trade relative to the NAV. At the end of the period the shares traded on a discount of 8.4% (on a cum-income basis with borrowings stated at fair value), compared to a discount of 2.9% at the beginning of the financial year. 

Your Investment Manager has continued to execute our strategy of investing in businesses of higher quality that meet our sustainable and responsible investment criteria and balancing attention between both income and capital growth potential. The portfolio continues to exhibit strong quality characteristics, while retaining a premium yield to, and superior dividend growth to, the FTSE All-Share Index. At the same time, it exhibits a high level of active share and stock specific risk reflecting a very differentiated approach to the wider index and many investment trusts in the peer group with similar objectives.

Against a flat market return, investment performance has been positive, aided by the Company's focus on higher quality areas of the market, coupled with good stock selection. In particular, we have seen strong performance from a number of the portfolio's holdings alongside continued merger and acquisition activity.

A detailed review of portfolio activity during the period is contained in the Investment Manager's Review.

Earnings and Dividends

Revenue earnings per share fell by 3.4% during the period to 8.25p (2022: 8.54p) per share. Importantly, underlying dividend income increased by 1.5% reflecting good trading from a number of our holdings, although the level of option income generated was lower than the equivalent period last year.

A first interim dividend in respect of the year ending 31 January 2024, of 3.2p (2023: 3.0p) per share, was paid on 25 August 2023 and the Board has declared a second interim dividend of 3.2p (2023: 3.0p) per share, which will be paid on 24 November 2023 to shareholders on the register on 3 November 2023. The rate of interim dividend was last increased in August 2018. The Board had been mindful that the increases in the overall annual rate of dividend since 2018 had caused the final dividend to become a growing percentage of the total annual payment. The Board therefore decided, and announced on declaring the first interim dividend, to increase the rate of each of the three interim dividends from 3.0p to 3.2p per share so as to create a more even balance between the rates of the interim and final dividends. The 6.7% increase in the rate of interim dividends therefore represents a rebalancing of dividend payments.

Based on last year's annual dividend of 13.1p per share, the dividend yield on the Company's shares was 4.6% at the end of the period. This is one of the higher yields available from the AIC's UK Equity Sector and is approximately 20% higher than the yield available from the UK equity market as measured by the FTSE All-Share Index.

In the year ahead, the Board's intention is to maintain a progressive dividend, substantially covered by earnings, although given the high level of inflation it is unlikely to increase in real terms, so as to allow the Company to continue to appropriately balance its focus on both capital and income generation. Our distribution policy, though, remains to grow the dividend faster than inflation over the medium term and, with the Company's robust revenue reserves, modest level of gearing and the healthy underlying dividend growth of the companies within the portfolio, that policy remains well supported.

Sustainability

Your Company continues to exhibit strong evidence of its sustainable positioning, elements that we believe will enhance the portfolio's long-term risk adjusted returns. Its carbon footprint is significantly lower than the benchmark. MSCI has assigned the Company an AA ESG rating and it is considered top decile out of all investment funds globally. The Investment Manager has continued to actively engage with the companies invested in, having addressed ESG specific issues with management teams at companies representing 28 of the holdings in the portfolio. Voting policy also forms an important part of the corporate engagement approach and the Investment Manager voted against management recommendations at least once in 21% of company general meetings held during the period.

Gearing

The Company currently employs two sources of gearing. The £30 million loan notes maturing in 2045, and a recently renewed one year £30 million multi-currency revolving credit facility with Bank of Nova Scotia that matures in July 2024. Under the terms of the facility the Company has the option to increase the level of the commitment from £30 million to £40 million at any time, subject to the lender's credit approval. A sterling equivalent of £13.4 million was drawn down under the facility at the end of the period.

With debt valued at par, the Company's net gearing increased from 7.1% to 9.7% during the period, reflecting lower cash balances at the period end, despite an increase in net assets due to capital appreciation. The Board believes this remains a relatively conservative level of gearing and, with the option to increase the revolving credit facility, provides the Company with financial flexibility should further opportunities to deploy capital arise.

Discount

As stated above, at the end of the period your Company's shares traded at a discount of 8.4% (on a cum-income basis with borrowings stated at fair value), compared to a discount of 2.9% at the beginning of the financial year.

Widening discounts were evident across the investment trust sector during the period. As a result of this, and in order to address the imbalance of supply and demand for the Company's shares, we bought back 22,055 shares to be held in treasury. With the higher level of discount persisting, we have bought back a further 400,863 shares since the period end. The Board believes that this action, together with continued delivery of investment performance, our commitment to grow the dividend faster than inflation over the medium-term and clear communication of the investment strategy should all help to improve the Company's current rating. The Board will continue to monitor the rating of your Company's shares carefully and make further use of both the Company's share buyback and issuance powers to address any imbalance of supply and demand in the Company's shares.

abrdn Investment Trust Savings Plans

The Board is aware that over 20% of the Company's shares are held through the abrdn Investment Trust Savings Plans (the "Plans"). These types of share schemes were the original and only means by which the shares of investment trusts could be made available to private investors. The development of whole of market platform offerings means other options are now available. abrdn has written to their clients in the Plans explaining that they will be closing in December 2023 and that the Plans will be transferring to the interactive investor platform. The Board continues to monitor this change. We would stress this has no impact on those holders' ability to receive communications from the Company, to vote and attend general meetings in person or to re-invest dividends.

Amendment to Investment Policy (Overseas Exposure)

As explained in the recent Annual Report, during the previous year, the Board and Investment Manager reviewed the guidelines governing the management of the portfolio and determined that the part of the investment policy relating to the limit on the exposure to investments in companies listed or quoted overseas should be amended from its previous limit of 20% to a new limit of 25%. The change took effect on 1 May 2023 and this higher limit provides the Investment Manager with greater flexibility to invest in overseas companies but does not represent a change in the way that the portfolio is managed.

The change was not a material change to the investment policy that would have required shareholder approval.

Outlook

The economic challenges to global growth continue to build, following rapid and sustained interest rate increases from central banks across the world, coupled with a Chinese economy facing significant headwinds. Despite some signs of easing, inflationary pressures remain significant in most economies and supply constraints are placing upward pressure on many commodity prices. In the UK, inflation remains too high and growth too low, albeit there are indications that a trough has been reached and perhaps somewhat ahead of other major economies. For equity markets, there remain reasons to be cautious and the next 18 months are likely to be a tough period for corporate earnings development. It is that very unpredictability of world and economic events that makes us concentrate on the companies within the portfolio and their ability to navigate the environment ahead of them.

As such, the approach of the Investment Manager is to balance the portfolio to handle a range of potential scenarios. There is an emphasis on protecting the downside from investing in companies with enduring business models, pricing power, robust balance sheets and strong management of their environmental, social and governance risks. At the same time, the Investment Manager is making sure that those businesses have the potential to participate in any upside opportunities that emerge, particularly stemming from powerful long-term structural drivers, dynamics likely to be less sensitive to the ups and downs of the economic cycle.

Our objectives remain to meet investor needs for capital and income returns over the medium and long term. We have again made good progress in this period. Whilst the global outlook is far from propitious, we believe our strategy of focussing on a concentrated and actively managed portfolio of high quality companies from across the UK and European markets with leading sustainability characteristics sets us up well to navigate conditions ahead.

 

David BarronChairman21 September 2023

Interim Management Statement

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

- The condensed set of financial statements has been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting';

- The Interim Board Report (constituting the interim management report) includes a fair review of the information required by DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and

- The financial statements include a fair review of the information required by DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during that period, and any changes in the related party transactions described in the last Annual Report that could do so.

Principal Risks and Uncertainties

The Board regularly reviews the principal risks and uncertainties faced by the Company together with the mitigating actions it has established to manage the risks. These are set out within the Strategic Report contained within the Annual Report for the year ended 31 January 2023 and comprise the following risk categories:

- Investment objectives

- Investment strategies

- Investment performance

- Income/dividends

- Financial/market

- Gearing

- Regulatory

- Operational

- Geo-political

The Company's principal risks and uncertainties have not changed materially since the date of the Annual Report and are not expected to change materially for the remaining six months of the Company's financial year.

Going Concern

The Company's assets consist mainly of equity shares in companies listed on the London Stock Exchange and in most circumstances are considered to be realisable within a short timescale. The Board has set limits for borrowing and derivative contract positions and regularly reviews actual exposures, cash flow projections and compliance with loan covenants. The Directors have considered the fact that the Company's investments comprise readily realisable securities which can be sold to meet funding requirements if necessary, and have taken into account the maturity of the £30 million multi-currency revolving credit facility in July 2024. The Directors have also performed stress testing on the portfolio and the loan financial covenants.

Having taken these matters into account, the Directors believe that the Company has adequate financial resources to continue in operational existence for the foreseeable future and for at least twelve months from the date of this Report. Accordingly, they continue to adopt the going concern basis of accounting in preparing the financial statements.

On behalf of the BoardDavid BarronChairman21 September 2023

Investment Manager's Review

Performance and Market Review

The UK market faced a number of headwinds in the first half of the Company's financial year; concerns about the financial stability of the banking sector, fears over persistent inflation and the continuing tightening of monetary policy. Despite this backdrop, the Company's net asset value ("NAV") appreciated during the six months to 31 July 2023 by 5.5% on a total return basis, outperforming the FTSE All-Share Index benchmark total return of 0.8%. Reassuringly, the rate of UK inflation looks to have passed its peak and is decelerating, driven by falling energy and food prices with positive implications for expected monetary policy. Overall, global economic data continues to be mixed, although ahead of where many expected going into the year. The exception is China, where activity levels have failed to rebound as much as anticipated following the post-Covid re-opening and there remain some worrying signs in both the shadow banking system and the real estate market. 

 

Outperformance in the portfolio was primarily driven by stock selection, consistent with our bottom up approach to portfolio construction. A number of the portfolio holdings reported positive results during the period. Games Workshop, the company behind the Warhammer game, delivered results ahead of expectations, alongside important new digital content developments. The European bottler Coca-Cola Hellenic Bottling Company continued to upgrade earnings expectations driven by strong demand and an attractive pricing environment. The accounting software provider Sage delivered an encouraging update that pointed to accelerating growth, driven by its US cloud native product Intacct. The portfolio also benefitted from its European holdings in Volvo, Edenred and Novo-Nordisk which continued to deliver good growth and solid results in the period. On the negative side, the holding in Asian insurer Prudential underperformed on concerns around the pace of China's recovery. In July, construction materials manufacturer Marshalls cut its guidance for the year on weaker end market demand, particularly from discretionary home improvements and new residential construction. However, the share price reaction was fairly muted suggesting that expectations had already adjusted and investors were starting to look through to end market recovery. We added to the position during the period given our assessment of the opportunity for attractive prospective returns when the cycle turns.

 

Pleasingly, dividend income delivery was ahead of our expectations over the period. Highlights included Games Workshop which nearly doubled its dividend from the prior year, Weir lifted its dividend by 37%, Sirius Real Estate increased its dividend by 30% and Nordea Bank grew its distribution by 16%. In contrast, only Marshalls announced a reduction in its dividend for the year. Given the timing of dividend declarations, our visibility over the income out-turn for this financial year is high. However, given the challenging outlook, we will continue to be watchful. It is worth noting that the Company's future dividend prospects are tied into businesses with exposure to structural as opposed to cyclical growth, stronger pricing power and, consequently, greater control over their own destiny. Ultimately, this will prove supportive if we enter into more economically challenging times.

 

We continued to generate income from option writing, though at a slower pace than the year before. We wrote puts over London Stock Exchange, Croda and Diageo where we were happy to add to the holdings and wrote calls over Nordea Bank, Coca Cola Hellenic Bottling Company and Pets at Home where we were comfortable to trim the holdings following strong performance. We anticipate that the second half of the year will yield more opportunities to generate additional option writing revenue.

 

During the period, we engaged with a number of companies in the portfolio in order to understand the key environmental, social and governance risks and opportunities facing them and share best practice. For example, we have been engaging with SSE as part of our Top 20 Financed Emitters project under our Net Zero framework. The company published a Net Zero Strategy earlier in the year in which it updated its targets and aligned to a 1.5 degrees Paris scenario certified by SBTi (Science Based Target Initiative). We are comfortable with the targets set given the nature of the utilities sector, although we continue to engage with the company on the potential to set short-team emissions targets and provide greater disclosure on Paris aligned capital expenditure. Weir is an ESG Improver held in the portfolio and as such we have set out a range of milestones for the company to monitor progress against. For example we have provided recommendations in relation to environmental impact disclosure, sustainable supply chain management and improving gender diversity. Being aware of these potential risks to companies' long-term strategies and looking to drive mitigation and create opportunities is a key part of our investment approach.

Portfolio Activity

We initiated a new position in Telecom Plus, a retailer of utility, telecom and insurance products, which operates in the UK under the Utility Warehouse brand. It has a capital-light business model that benefits from its low fixed cost base, network of sales agents and breadth of product offering. Its competitive positioning in the market has continued to improve and we see attractive opportunities for long term growth in customers, revenues and shareholder distributions alongside a strong balance sheet. We also introduced the UK's largest IT value added reseller Softcat to the portfolio. We believe Softcat has significant potential for long-term growth, coupled with a strong balance sheet and the optionality for enhanced shareholder cash returns. Alongside these purchases we also acquired a new position in German automotive manufacturer Mercedes-Benz which is repositioning its strategy towards the luxury end of the market and is well positioned from a technology perspective to meet the challenges of the electric vehicle transition and the gradual move to autonomous driving.

 

To fund these new ideas, we exited small holdings in lower conviction names Direct Line Insurance, Ashmore and Ubisoft. We also took the opportunity to exit Dechra Pharmaceuticals after it received an all-cash offer from private equity company EQT and the private equities investment department of Abu Dhabi Investment Authority.

Outlook

We retain the relatively cautious market outlook that we have had for some time. That said, we remain very positive on the potential long-term returns available from the portfolio. We also see selected value in a number of domestically focussed cyclical stocks. In addition, the Company benefits from diversification and the opportunity to invest a portion of assets outside the UK. Currently we have more opportunities to deploy capital than has been the case for a considerable period. Overall, we will continue to seek to keep a balance to our positioning, giving ourselves the potential to perform in a range of market environments. Our primary attention remains on seeking to protect capital, but we will continue to look to participate in opportunities where share prices in good companies with attractive long term prospects have been oversold and, at the same time, focus on those that meet our sustainable and responsible investing criteria.

 

Ben Ritchie and Rebecca Macleanabrdn Investments Limited21 September 2023

Investment Portfolio

At 31 July 2023

Market value

Total assets

Company

Sector

£'000

%

AstraZeneca

Pharmaceuticals and Biotechnology

45,174

9.0

Unilever

Personal Care, Drug and Grocery Stores

35,877

7.2

RELX

Media

27,055

5.4

TotalEnergies

Oil, Gas and Coal

25,998

5.2

Diageo

Beverages

24,465

4.9

London Stock Exchange

Finance and Credit Services

22,424

4.5

SSE

Electricity

20,786

4.1

Coca-Cola Hellenic Bottling Company

Beverages

17,358

3.5

Chesnara

Life Insurance

16,014

3.2

Games Workshop

Leisure Goods

15,858

3.1

Ten largest equity investments

251,009

50.1

Prudential

Life Insurance

14,524

2.9

Intermediate Capital

Investment Banking and Brokerage Services

12,604

2.5

Sage

Software and Computer Services

12,126

2.4

Weir

Industrial Engineering

11,999

2.4

Taylor Wimpey

Household Goods and Home Construction

11,636

2.3

Croda

Chemicals

11,251

2.3

M&G

Investment Banking and Brokerage Services

11,107

2.2

Edenred

Industrial Support Services

10,752

2.2

ASML

Technology Hardware and Equipment

10,724

2.1

Pets At Home

Retailers

10,612

2.1

Twenty largest equity investments

368,344

73.5

Close Brothers

Banks

10,433

2.1

Hiscox

Non-life Insurance

10,419

2.1

Volvo

Industrial Transportation

10,374

2.1

Mercedes-Benz

Automobiles and Parts

10,334

2.0

Nordea Bank

Banks

9,960

2.0

Sirius Real Estate

Real Estate Investment Trusts

9,428

1.9

Telecom Plus

Telecommunications Service Providers

9,414

1.9

Morgan Sindall

Construction and Materials

9,386

1.9

Assura

Real Estate Investment Trusts

9,329

1.8

Marshalls

Construction and Materials

8,539

1.7

Thirty largest equity investments

465,960

93.0

Novo-Nordisk

Pharmaceuticals and Biotechnology

8,244

1.7

Oxford Instruments

Electronic and Electrical Equipment

6,632

1.3

Softcat

Software and Computer Services

6,594

1.3

Moonpig

Retailers

5,303

1.1

Genus

Pharmaceuticals and Biotechnology

5,109

1.0

Total equity investments

497,842

99.4

Net current assetsA

3,092

0.6

Total assets less current liabilities (excluding borrowings)

500,934

100.0

A Excluding bank loan of £13,368,000 and bank overdraft of £1,214,000.

Condensed Statement of Comprehensive Income (unaudited)

Six months ended

Six months ended

31 July 2023

31 July 2022

Revenue

Capital

Total

Revenue

Capital

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

Gains/(losses) on investments

-

7,192

7,192

-

(16,343)

(16,343)

Income

2

13,776

-

13,776

13,989

-

13,989

Investment management fees

(352)

(527)

(879)

(348)

(522)

(870)

Administrative expenses

(541)

-

(541)

(462)

-

(462)

Currency gains/(losses)

-

227

227

-

(15)

(15)

Net return before finance costs and tax

12,883

6,892

19,775

13,179

(16,880)

(3,701)

Finance costs

(353)

(523)

(876)

(287)

(415)

(702)

Return before taxation

12,530

6,369

18,899

12,892

(17,295)

(4,403)

Taxation

3

(305)

-

(305)

(225)

-

(225)

Return after taxation

12,225

6,369

18,594

12,667

(17,295)

(4,628)

Return per Ordinary share (pence)

5

8.25

4.29

12.54

8.54

(11.66)

(3.12)

The total column of the Condensed Statement of Comprehensive Income is the profit and loss account of the Company.  

All revenue and capital items in the above statement derive from continuing operations.

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Financial Position (unaudited)

As at

As at

31 July 2023

31 January 2023

Note

£'000

£'000

Non-current assets

Investments at fair value through profit or loss

9

497,842

478,895

Current assets

Debtors

4,165

2,452

Cash and short-term deposits

-

12,267

4,165

14,719

Creditors: amounts falling due within one year

Bank loan

(13,368)

(13,762)

Bank overdraft

(1,214)

-

Other creditors

(1,073)

(1,509)

(15,655)

(15,271)

Net current liabilities

(11,490)

(552)

Total assets less current liabilities

486,352

478,343

Creditors: amounts falling due after more than one year

Loan Notes 2045

(29,742)

(29,738)

Net assets

456,610

448,605

Capital and reserves

Called-up share capital

38,419

38,419

Share premium account

4,908

4,908

Capital redemption reserve

1,606

1,606

Capital reserve

6

386,146

379,839

Revenue reserve

25,531

23,833

Equity shareholders' funds

456,610

448,605

Net asset value per Ordinary share (pence)

7

308.02

302.57

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Changes in Equity (unaudited)

Six months ended 31 July 2023 

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 January 2023

38,419

4,908

1,606

379,839

23,833

448,605

Return after taxation

-

-

-

6,369

12,225

18,594

Purchase of own shares for treasury

-

-

-

(62)

-

(62)

Dividends paid

4

-

-

-

-

(10,527)

(10,527)

Balance at 31 July 2023

38,419

4,908

1,606

386,146

25,531

456,610

Six months ended 31 July 2022

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 January 2022

38,419

4,619

1,606

396,303

23,632

464,579

Return after taxation

-

-

-

(17,295)

12,667

(4,628)

Issue of shares from treasury

-

289

-

-

-

289

Dividends paid

4

-

-

-

-

(10,227)

(10,227)

Balance at 31 July 2022

38,419

4,908

1,606

379,008

26,072

450,013

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Cash Flows (unaudited)

Six months ended

Six months ended

31 July 2023

31 July 2022

£'000

£'000

Operating activities

Net return/ (loss) before finance costs and taxation

19,775

(3,701)

Adjustments for:

(Gains)/losses on investments

(7,192)

16,343

Currency (gains)/losses

(227)

15

Increase in accrued dividend income

(623)

(1,377)

Stock dividends included in dividend income

(432)

-

Decrease/(increase) in other debtors excluding tax

144

(626)

Increase in other creditors

111

435

Net tax paid

(944)

(225)

Net cash inflow from operating activities

10,612

10,864

Investing activities

Purchases of investments

(57,296)

(36,244)

Sales of investments

44,824

40,939

Net cash (used in)/from investing activities

(12,472)

4,695

Financing activities

Interest paid

(921)

(686)

Dividends paid

(10,527)

(10,227)

Purchase of own shares for treasury

(6)

-

Share issue proceeds

-

289

Loan repayment

(394)

-

Net cash used in financing activities

(11,848)

(10,624)

(Decrease)/increase in cash and cash equivalents

(13,708)

4,935

Analysis of changes in cash and cash equivalents during the period

Opening balance

12,267

2,855

Effect of exchange rate fluctuations on cash held

227

22

(Decrease)/increase in cash as above

(13,708)

4,935

Closing balance

(1,214)

7,812

The accompanying notes are an integral part of the financial statements.

Notes to the Financial Statements (unaudited)

1.

Accounting policies

Basis of preparation. The condensed financial statements have been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting' and with the Statement of Recommended Practice for 'Financial Statements of Investment Trust Companies and Venture Capital Trusts', issued in July 2022. They have also been prepared on a going concern basis and on the assumption that status as an investment trust will be maintained.

The half yearly financial statements have been prepared using the same accounting policies and methods of computation as the preceding annual financial statements (year ended 31 January 2023), which were prepared in accordance with Financial Reporting Standard 102.

 

2.

Income

Six months ended

Six months ended

31 July 2023

31 July 2022

£'000

£'000

Income from investments

UK dividend income

6,983

8,348

Overseas dividends

5,642

4,512

Stock dividends

432

-

13,057

12,860

Other income

Income on derivatives

684

1,127

Interest income

35

2

719

1,129

Total income

13,776

13,989

 

3.

Taxation

The taxation charge for the period, and the comparative period, represents withholding tax suffered on overseas dividend income.

 

4.

Ordinary dividends on equity shares

Six months ended

Six months ended

31 July 2023

31 July 2022

£'000

£'000

Third interim dividend 2023 of 3.00p (2022 - 3.00p)

4,448

4,445

Final dividend 2023 of 4.10p (2022 - 3.90p)

6,079

5,782

10,527

10,227

A first interim dividend in respect of the year ending 31 January 2024 of 3.20p per Ordinary share (2023 - 3.00p) was paid on 25 August 2023 to shareholders on the register on 4 August 2023. The ex-dividend date was 3 August 2023.  

 

5.

Returns per share

Six months ended

Six months ended

31 July 2023

31 July 2022

p

p

Revenue return

8.25

8.54

Capital return

4.29

(11.66)

Total return

12.54

(3.12)

The returns per share are based on the following:

Six months ended

Six months ended

31 July 2023

31 July 2022

£'000

£'000

Revenue return

12,225

12,667

Capital return

6,369

(17,295)

Total return

18,594

(4,628)

Weighted average number of Ordinary shares

148,264,249

148,248,095

 

6.

Capital reserves

The capital reserve reflected in the Condensed Statement of Financial Position at 31 July 2023 includes gains of £75,872,000 (31 January 2023 - gains of £54,080,000) which relate to the revaluation of investments held at the reporting date.

 

7.

Net asset value

Equity shareholders' funds have been calculated in accordance with the provisions of Financial Reporting Standard 102. The analysis of equity shareholders' funds on the face of the Condensed Statement of Financial Position does not reflect the rights under the Articles of Association of the Ordinary shareholders on a return of assets. These rights are reflected in the net asset value and the net asset value per share attributable to Ordinary shareholders at the period end, adjusted to reflect the deduction of the Loan Notes at par. A reconciliation between the two sets of figures is as follows:

31 July 2023

31 January 2023

Net assets attributable (£'000)

456,610

448,605

Number of Ordinary shares in issue at the period endA

148,242,615

148,264,670

Net asset value per Ordinary share

308.02p

302.57p

A Excluding shares held in treasury

31 July 2023

31 January 2023

Adjusted net assets

£'000

£'000

Net assets attributable (as above)

456,610

448,605

Unamortised Loan Notes issue expenses

(258)

(262)

Adjusted net assets attributable

456,352

448,343

Number of Ordinary shares in issue at the period endA

148,242,615

148,264,670

Adjusted net asset value per Ordinary share

307.84p

302.39p

A Excluding shares held in treasury.

31 July 2023

31 January 2023

Net assets - debt at fair value

£'000

£'000

Net assets attributable

456,610

448,605

Amortised cost Loan Notes

29,742

29,738

Market value Loan Notes

(23,577)

(29,393)

Net assets attributable

462,775

448,950

Number of Ordinary shares in issue at the period endA

148,242,615

148,264,670

Net asset value per Ordinary share - debt at fair value

312.17p

302.80p

A Excluding shares held in treasury.

 

8.

Transaction costs

During the period expenses were incurred in acquiring or disposing of investments classified as fair value through profit or loss. These have been expensed through capital and are included within gains/(losses) on investments in the Condensed Statement of Comprehensive Income. The total costs were as follows:

Six months ended

Six months ended

31 July 2023

31 July 2022

£'000

£'000

Purchases

151

146

Sales

25

23

176

169

 

9.

Fair value hierarchy

FRS 102 requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following classifications:  

Level 1: unadjusted quoted prices in an active market for identical assets or liabilities that the entity can access at the measurement date.

Level 2: inputs other than quoted prices included within Level 1 that are observable (ie developed using market data) for the asset or liability, either directly or indirectly.  

Level 3: inputs are unobservable (ie for which market data is unavailable) for the asset or liability.  

The financial assets and liabilities measured at fair value in the Condensed Statement of Financial Position are grouped into the fair value hierarchy at the reporting date as follows:  

Level 1

Level 2

Level 3

Total

As at 31 July 2023

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

497,842

-

-

497,842

Total

497,842

-

-

497,842

Level 1

Level 2

Level 3

Total

As at 31 January 2023

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

478,895

-

-

478,895

Total

478,895

-

-

478,895

a)

Quoted equities. The fair value of the Company's investments in quoted equities has been determined by reference to their quoted bid prices at the reporting date. Quoted equities included in Fair Value Level 1 are actively traded on recognised stock exchanges.

 

10.

Analysis of changes in net debt

At

Currency

Non-cash

At

31 January 2023

differences

Cash flows

movements

31 July 2023

£'000

£'000

£'000

£'000

£'000

Cash and cash equivalents/(bank overdraft)

12,267

227

(13,708)

-

(1,214)

Debt due within one year

(13,762)

43

351

-

(13,368)

Debt due after more than one year

(29,738)

-

-

(4)

(29,742)

(31,233)

270

(13,357)

(4)

(44,324)

At

Currency

Non-cash

At

31 January 2022

differences

Cash flows

movements

31 July 2022

Analysis of changes in net debt

£'000

£'000

£'000

£'000

£'000

Cash and cash equivalents

2,855

22

4,935

-

7,812

Debt due within one year

(13,034)

(37)

-

-

(13,071)

Debt due after more than one year

(29,731)

-

-

(3)

(29,734)

(39,910)

(15)

4,935

(3)

(34,993)

A statement reconciling the movement in net funds to the net cash flow has not been presented as there are no differences from the above analysis.

 

11.

Transactions with the Manager

The Company has an agreement with the abrdn Fund Managers Limited (the "Manager") for the provision of investment management, secretarial, accounting and administration and promotional activity services.

The management fee is calculated and charged, on a monthly basis, at 0.45% per annum on the first £225 million, 0.35% per annum on the next £200 million and 0.25% per annum on amounts over £425 million of the net assets of the Company, with debt at par and excluding commonly managed funds. The management fee is chargeable 40% to revenue and 60% to capital. During the period £879,000 (31 July 2022 - £870,000) of investment management fees were payable to the Manager, with a balance of £291,000 (31 July 2022 - £430,000) being due at the period end. There were no commonly managed funds held in the portfolio during the six months to 31 July 2023 (2022 - none).

The management agreement may be terminated by either party on not less than six months' written notice. On termination by the Company on less than the agreed notice period the Manager would be entitled to receive fees which would otherwise have been due up to that date.

The Manager also receives a separate promotional activities fee which is based on a current annual amount of £250,000 plus VAT payable quarterly in arrears. During the period £125,000 plus VAT (31 July 2022 - £121,000 plus VAT) of fees were payable to the Manager, with a balance of £83,000 plus VAT (31 July 2022 - £81,000 plus VAT) being due at the period end.

 

12.

Segmental information

The Company is engaged in a single segment of business, which is to invest mainly in equity securities. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based on the Company as one segment.

 

13.

Half Yearly Financial Report

The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 31 July 2023 and 31 July 2022 has not been audited.

The information for the year ended 31 January 2023 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditor on those accounts contained no qualification or statement under Section 498 of the Companies Act 2006.

 

14.

Approval

This Half Yearly Financial Report was approved by the Board on 21 September 2023.

Alternative Performance Measures ("APMs")

 

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes FRS 102 and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies. 

Discount to net asset value per share with debt at fair value

The (discount)/premium is the amount by which the share price is lower than the net asset value per share with debt at fair value, expressed as a percentage of the net asset value with debt at fair value.

31 July 2023

31 January 2023

Share price (p)

a

286.00p

294.00p

NAV per Ordinary share (p)

b

312.17p

302.80p

Discount

(a-b)/a

8.4%

2.9%

Dividend yield

Dividend yield is calculated using the Company's historic annual dividend per Ordinary share divided by the share price, expressed as a percentage.  

31 July 2023

31 January 2023

Annual dividend per Ordinary share (p)

a

13.10p

13.10p

Share price (p)

b

286.00p

294.00p

Dividend yield

a/b

4.6%

4.5%

Net gearing  

Net gearing measures total borrowings less cash and cash equivalents divided by shareholders' funds, expressed as a percentage. Under AIC reporting guidance cash and cash equivalents includes net amounts due to and from brokers at the period end as well as cash and short term deposits.  

31 July 2023

31 January 2023

Borrowings (£'000)

a

44,324

43,500

Cash (£'000)

b

-

12,267

Amounts due to brokers (£'000)

c

57

649

Amounts due from brokers (£'000)

d

-

-

Shareholders' funds (£'000)

e

456,610

448,605

Net gearing

(a-b+c-d)/e

9.7%

7.1%

Total return

NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. Share price and NAV total returns are monitored against open-ended and closed-ended competitors, and the Reference Index, respectively.  

Share

Six months ended 31 July 2023

NAV

Price

Opening at 1 February 2023

a

302.8p

294.0p

Closing at 31 July 2023

b

312.2p

286.0p

Price movements

c=(b/a)-1

+3.1%

(2.7)%

Dividend re-investmentA

d

+2.4%

+2.3%

Total return

c+d

+5.5%

(0.4)%

Share

Year ended 31 January 2023

NAV

Price

Opening at 1 February 2022

a

309.0p

310.0p

Closing at 31 January 2023

b

302.8p

294.0p

Price movements

c=(b/a)-1

(2.0)%

(5.2)%

Dividend re-investmentA

d

+4.4%

+4.3%

Total return

c+d

+2.4%

(0.9)%

A NAV total return involves investing the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend. Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.  

 

By order of the Board

abrdn Holdings Limited

Company Secretary

21 September 2023

 

Please note that past performance is not necessarily a guide to the future and the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVRAEIIFIV
Date   Source Headline
26th Apr 20245:28 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20245:30 pmRNSTransaction in Own Shares
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:46 pmRNSTransaction in Own Shares
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20245:13 pmRNSTransaction in Own Shares
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:18 pmRNSNet Asset Value(s)
19th Apr 202412:45 pmRNSNet Asset Value(s)
18th Apr 20245:14 pmRNSTransaction in Own Shares
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:24 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20242:37 pmRNSDoc re. Annual Report
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:42 pmRNSPortfolio Disclosures
15th Apr 20245:12 pmRNSTransaction in Own Shares
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 20243:01 pmRNSInvestor Presentation - 10am, 7 May 2024
15th Apr 202412:43 pmRNSNet Asset Value(s)
12th Apr 20245:27 pmRNSTransaction in Own Shares
12th Apr 202412:56 pmRNSNet Asset Value(s)
11th Apr 20245:17 pmRNSTransaction in Own Shares
11th Apr 202412:41 pmRNSNet Asset Value(s)
10th Apr 20245:30 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:19 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 20245:18 pmRNSTransaction in Own Shares
4th Apr 202412:47 pmRNSNet Asset Value(s)
4th Apr 20247:00 amRNSAnnual Financial Report
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:08 amRNSTotal Voting Rights
28th Mar 20245:42 pmRNSTransaction in Own Shares
28th Mar 20243:15 pmRNSNet Asset Value(s)
27th Mar 20245:24 pmRNSTransaction in Own Shares
27th Mar 202412:18 pmRNSNet Asset Value(s)
26th Mar 20245:15 pmRNSTransaction in Own Shares
26th Mar 202412:23 pmRNSNet Asset Value(s)
25th Mar 20245:31 pmRNSTransaction in Own Shares
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.